[MOL] Drug Therapy -Series [02825] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Drug Therapy -Series



flutamide 

Tradename Eulexin 
Manufacturer Schering 
Treatment Class Endocrine and metabolic 
Indication Metastatic prostatic carcinoma 
MSB Review: Focus On... The Prostate 
Med-Brief: Flutamide and Surgical Removal of Testes: Effect on Survival
Rate of Metastatic Prostate Cancer Patients - Oct 98 
Med-Brief: Post-castration Drug Therapy in Advanced Prostate Cancer
Patients - Nov 98


gemcitabine 

Tradename Gemzar 
Manufacturer Lilly 
Treatment Class Oncology 
Indication Pancreatic cancer 
MSB Review: Gemcitabine Approved for Pancreatic Cancer 
MSB Review: Topotecan Approved for Ovarian Cancer 
PNN Review Breast Cancer Symposium Opens in San Antonio 


gemcitabine 

Tradename Gemzar 
Manufacturer Lilly 
Treatment Class Oncology 
Indication Pancreatic cancer 
MSB Review: Gemcitabine Approved for Pancreatic Cancer 
MSB Review: Topotecan Approved for Ovarian Cancer 
PNN Review Breast Cancer Symposium Opens in San Antonio 

granisetron 

Tradename Kytril 
Manufacturer SmithKline Beecham 
Treatment Class Psychopharmacologic and Neurologic (CNS) 
Indication Chemotherapy-induced vomiting 
MSB Review: Granisetron Approved for Chemotherapy-induced Vomiting 
MSB Review: Oral Granisetron Antiemetic for High-dose Chemotherapy 
MSB Review: Oral Ondansetron Indication Expanded to Post-Op Nausea and
Vomiting 
MSB Review: Dolasetron for Chemotherapy-induced Nausea 

irinotecan 

Tradename Campto, Camptosar 
Manufacturer Rhone-Poulenc Rorer Inc., Pharmacia & Upjohn 
Treatment Class Oncology 
Indication Advanced colorectal cancer 
DrugPR: STUDIES DEMONSTRATE HIGH ACTIVITY OF CAMPTO(R) AS TREATMENT FOR
COLORECTAL CANCER 
DrugPR: FDA APPROVAL OF COLORECTAL CANCER TREATMENT -- FIRST TO BE BASED ON
SURVIVAL DATA - October 23, 1998 
MSB Review: Topotecan Approved for Ovarian Cancer 
MSB Review: Irinotecan Approved for Advanced Colorectal Cancer 
Med-Brief: Drug Treatment of Advanced Colorectal Cancer - Nov 98 




------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------